1.
Jeong S, Tsai M-J, Shen C, Hsu Y-H. Falls, fracture and frailty risk in multiple sclerosis: a Mendelian Randomization study to identify shared genetics. Journal of bone and mineral metabolism. 2024. doi:10.1007/s00774-024-01504-8.
1.
Schuurmans IK, Dunn EC, Lussier AA. DNA methylation as a possible causal mechanism linking childhood adversity and health: Results from two-sample mendelian randomization study. American journal of epidemiology. 2024. doi:10.1093/aje/kwae072.
1.
Bouras E, Gill D, Zuber V, et al. Identification of potential mediators of the relationship between body mass index and colorectal cancer: a Mendelian randomization analysis. International journal of epidemiology. 2024;53(3). doi:10.1093/ije/dyae067.
1.
Carrasquilla GD, García-Ureña M, Romero-Lado MJ, Kilpeläinen TO. Estimating causality between smoking and abdominal obesity by Mendelian randomization. Addiction (Abingdon, England). 2024. doi:10.1111/add.16454.
1.
Wang B, Dron JS, Wang Y, et al. Lipid levels and risk of acute pancreatitis using bidirectional Mendelian randomization. Scientific reports. 2024;14(1):6267. doi:10.1038/s41598-024-56946-x.
1.
Jin J, Qi G, Yu Z, Chatterjee N. Mendelian randomization analysis using multiple biomarkers of an underlying common exposure. Biostatistics (Oxford, England). 2024. doi:10.1093/biostatistics/kxae006.
1.
Leung PBM, Liu Z, Zhong Y, et al. Bidirectional two-sample Mendelian randomization study of differential white blood cell counts and schizophrenia. Brain, behavior, and immunity. 2024. doi:10.1016/j.bbi.2024.02.015.
1.
Leung PBM, Liu Z, Zhong Y, et al. Bidirectional two-sample Mendelian randomization study of differential white blood cell counts and schizophrenia. Brain, behavior, and immunity. 2024. doi:10.1016/j.bbi.2024.02.015.
1.
Papadimitriou N, Qu C, Harrison TA, et al. Body size and risk of colorectal cancer molecular defined subtypes and pathways: Mendelian randomization analyses. EBioMedicine. 2024;101:105010. doi:10.1016/j.ebiom.2024.105010.
1.
Koller D, Mitjans M, Kouakou M, et al. Genetic contribution to the comorbidity between attention-deficit/hyperactivity disorder and substance use disorders. Psychiatry research. 2024;333:115758. doi:10.1016/j.psychres.2024.115758.